# Thibiant International, Inc. – FDA Inspection, Mar 15, 2018

Source: https://www.keypedia.com/records/fda_inspections/thibiant-international-inc/0d00bc22-ad30-468b-bea0-07b5c6d4073e
Source feed: FDA_Inspections

> FDA inspection 1044966 of Thibiant International, Inc., March 15, 2018. 5 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1044966
- Company Name: Thibiant International, Inc.
- Inspection Date: 2018-03-15
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 5

## Related Documents

- [FDA Inspection 891800 - 2014-08-19](https://www.keypedia.com/records/fda_inspections/thibiant-international-inc/390b3151-3dd2-4815-982c-add40098dd2a)
- [FDA Inspection 850661 - 2013-09-26](https://www.keypedia.com/records/fda_inspections/thibiant-international-inc/bb639a30-d9cd-475c-82f7-728434ad0d15)
- [FDA Inspection 592220 - 2009-06-25](https://www.keypedia.com/records/fda_inspections/thibiant-international-inc/78b932bc-3606-462d-8df6-3f9d2da0b7a5)

## Related Officers

- [Investigator](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)

Company: https://www.keypedia.com/companies/thibiant-international-inc/5df84acc-2ce1-4b93-9b6b-f7e8379490fe

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b